ARS Pharmaceuticals Statistics
Total Valuation
SPRY has a market cap or net worth of $839.11 million. The enterprise value is $615.70 million.
| Market Cap | 839.11M |
| Enterprise Value | 615.70M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, after market close.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SPRY has 96.90 million shares outstanding. The number of shares has increased by 2.40% in one year.
| Shares Outstanding | 96.90M |
| Shares Change (YoY) | +2.40% |
| Shares Change (QoQ) | +0.37% |
| Owned by Insiders (%) | 23.47% |
| Owned by Institutions (%) | 62.23% |
| Float | 42.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 83,911.33 |
| Forward PS | 90.40 |
| PB Ratio | 3.75 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 61,569.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 60.90, with a Debt / Equity ratio of 0.00.
| Current Ratio | 60.90 |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -21.10% and return on invested capital (ROIC) is -27.67%.
| Return on Equity (ROE) | -21.10% |
| Return on Assets (ROA) | -20.50% |
| Return on Capital (ROIC) | -27.67% |
| Revenue Per Employee | $417 |
| Profits Per Employee | -$2.07M |
| Employee Count | 24 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +28.68% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +28.68% |
| 50-Day Moving Average | 8.76 |
| 200-Day Moving Average | 6.79 |
| Relative Strength Index (RSI) | 51.71 |
| Average Volume (20 Days) | 703,087 |
Short Selling Information
The latest short interest is 6.85 million, so 7.07% of the outstanding shares have been sold short.
| Short Interest | 6.85M |
| Short Previous Month | 6.82M |
| Short % of Shares Out | 7.07% |
| Short % of Float | 15.95% |
| Short Ratio (days to cover) | 18.22 |
Income Statement
In the last 12 months, SPRY had revenue of $10,000 and -$49.70 million in losses. Loss per share was -$0.52.
| Revenue | 10,000 |
| Gross Profit | 10,000 |
| Operating Income | -62.00M |
| Pretax Income | -49.70M |
| Net Income | -49.70M |
| EBITDA | -49.63M |
| EBIT | -49.70M |
| Loss Per Share | -$0.52 |
Balance Sheet
The company has $223.63 million in cash and $217,000 in debt, giving a net cash position of $223.42 million or $2.31 per share.
| Cash & Cash Equivalents | 223.63M |
| Total Debt | 217,000 |
| Net Cash | 223.42M |
| Net Cash Per Share | $2.31 |
| Equity (Book Value) | 223.87M |
| Book Value Per Share | 2.31 |
| Working Capital | 222.53M |
Cash Flow
In the last 12 months, operating cash flow was -$53.55 million and capital expenditures -$65,000, giving a free cash flow of -$53.61 million.
| Operating Cash Flow | -53.55M |
| Capital Expenditures | -65,000 |
| Free Cash Flow | -53.61M |
| FCF Per Share | -$0.56 |
Margins
Gross margin is 100.00%, with operating and profit margins of -619,990.00% and -496,960.00%.
| Gross Margin | 100.00% |
| Operating Margin | -619,990.00% |
| Pretax Margin | -496,960.00% |
| Profit Margin | -496,960.00% |
| EBITDA Margin | -496,320.00% |
| EBIT Margin | -496,960.00% |
| FCF Margin | -536,120.00% |
Dividends & Yields
SPRY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.40% |
| Shareholder Yield | -2.40% |
| Earnings Yield | -5.92% |
| FCF Yield | -6.39% |
Analyst Forecast
The average price target for SPRY is $18.50, which is 113.63% higher than the current price. The consensus rating is "Buy".
| Price Target | $18.50 |
| Price Target Difference | 113.63% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 617.42% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SPRY has an Altman Z-Score of 135.1 and a Piotroski F-Score of 1.
| Altman Z-Score | 135.1 |
| Piotroski F-Score | 1 |